Synonym |
Ac-Tyr(PO3H2)-Tyr(PO3H2)-Tyr(PO3H2)-Ile-Glu-OH |
Species |
N/A |
Protein Accession |
N/A |
Purity |
N/A |
Endotoxin Level |
N/A |
Biological Activity |
N/A |
Expression System |
N/A |
Fusion Tag |
N/A |
Predicted Molecular Mass |
N/A |
Formulation |
N/A |
Reconstitution |
N/A |
Storage & Stability |
N/A |
FAQ
What is Ac-Tyr(PO3H2)-Tyr(PO3H2)-Tyr(PO3H2)-Ile-Glu-OH, and what are its main
applications?
Ac-Tyr(PO3H2)-Tyr(PO3H2)-Tyr(PO3H2)-Ile-Glu-OH, often referred to as a
phosphorylated peptide, plays a significant role in biochemical research, particularly in the study of
signal transduction pathways. In biological systems, phosphorylation is a crucial post-translational
modification that regulates protein activity, interactions, and localization, thus influencing various
cellular processes. This synthetic peptide serves as a powerful tool for scientists to mimic and
understand the roles of phosphorylated proteins in cellular signaling.
Its structure, comprising
three phosphorylated tyrosine residues, makes it particularly valuable in the context of research
involving protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs). These enzymes, which
add and remove phosphate groups from tyrosine residues, respectively, are major players in pathways
controlling cell growth, differentiation, and apoptosis. By studying peptides like
Ac-Tyr(PO3H2)-Tyr(PO3H2)-Tyr(PO3H2)-Ile-Glu-OH, researchers can gain insights into abnormal
phosphorylation events associated with diseases such as cancer, diabetes, and neurological
disorders.
In addition, this peptide serves as a substrate or inhibitor in various in vitro
assays used to screen for potential therapeutic agents targeting tyrosine phosphatases and kinases. Its
phosphorylated tyrosine residues make it a suitable mimic of natural substrates, providing a reliable
means to assess enzyme activity and specificity. Moreover, it can be incorporated into experimental
systems such as mass spectrometry to study kinase-substrate interactions and to map phosphorylation
sites. Through these applications, Ac-Tyr(PO3H2)-Tyr(PO3H2)-Tyr(PO3H2)-Ile-Glu-OH not only advances our
fundamental understanding of cell signaling but also aids in the discovery of novel drug candidates for
diseases characterized by dysregulated phosphorylation.
How does the presence of phosphorylated
tyrosine residues in Ac-Tyr(PO3H2)-Tyr(PO3H2)-Tyr(PO3H2)-Ile-Glu-OH affect its biochemical
properties?
The presence of three phosphorylated tyrosine residues in
Ac-Tyr(PO3H2)-Tyr(PO3H2)-Tyr(PO3H2)-Ile-Glu-OH significantly affects the peptide's biochemical
properties and functional behavior. Phosphorylation introduces negative charges to the peptide structure
due to the phosphate groups, which alters its conformation, solubility, and interaction characteristics.
These modifications are crucial for mimicking the dynamic changes in proteins that occur through
phosphorylation, providing valuable insights into cellular signaling mechanisms.
Firstly, the
introduction of negatively charged phosphate groups influences the peptide's solubility in aqueous
environments. This can enhance its stability and make it more suitable for various experimental
conditions where solubility is a factor. However, it may also necessitate specific buffer systems to
maintain its solubility, especially in highly concentrated solutions. Researchers need to consider these
aspects when designing experiments involving this peptide.
Secondly, the charge introduced by the
phosphate groups can alter the peptide's conformation, impacting how it interacts with other molecules,
including proteins, enzymes, and cellular membranes. This is particularly important when studying the
role of phosphorylated residues in protein-protein interactions, where changes in charge and
conformation can dictate binding affinity and specificity. As such,
Ac-Tyr(PO3H2)-Tyr(PO3H2)-Tyr(PO3H2)-Ile-Glu-OH serves as an excellent model system to understand these
complex interactions under experimental conditions.
Lastly, the phosphorylated tyrosine residues
make this peptide an attractive target or substrate for specific proteins, such as SH2 domains, which
bind phosphorylated tyrosines in signaling proteins. This interaction forms the basis of many signaling
pathways that regulate critical cellular processes, including cell division, migration, and apoptosis.
Researchers use this peptide to uncover the molecular determinants of such interactions and to design
inhibitors that block aberrant signaling pathways in diseases like cancer.
How can
Ac-Tyr(PO3H2)-Tyr(PO3H2)-Tyr(PO3H2)-Ile-Glu-OH be utilized in drug discovery and
development?
Ac-Tyr(PO3H2)-Tyr(PO3H2)-Tyr(PO3H2)-Ile-Glu-OH is a valuable asset in the field of
drug discovery and development, particularly concerning diseases associated with dysfunctional
phosphorylation events, such as cancer, inflammatory disorders, and metabolic conditions. In the drug
discovery pipeline, it serves several purposes, from the initial screening of drug candidates to the
characterization of potential therapeutic targets.
One of the principal applications of this
peptide in drug discovery is its role as a substrate in high-throughput screening (HTS) assays. These
assays aim to evaluate the activity of compounds against a variety of protein kinases and phosphatases,
a class of enzymes heavily implicated in abnormal cell signaling pathways in disease states. As a
synthetic mimic of phosphorylated proteins, Ac-Tyr(PO3H2)-Tyr(PO3H2)-Tyr(PO3H2)-Ile-Glu-OH provides a
reliable and consistent substrate against which to measure enzyme activity or inhibition levels, aiding
in the identification of novel inhibitors or activators that may serve as therapeutic
agents.
Furthermore, this peptide can help elucidate the mechanism of action of potential drugs.
By studying how pharmaceutical compounds alter the interaction between the peptide and its target
enzymes, researchers can gather insights into the biochemical pathways affected by these drugs. This
information is crucial for optimizing lead compounds, improving their efficacy, and reducing off-target
effects, which is a significant challenge in drug development.
Another critical role of
Ac-Tyr(PO3H2)-Tyr(PO3H2)-Tyr(PO3H2)-Ile-Glu-OH is in structure-activity relationship (SAR) studies.
Through these studies, chemists can modify the peptide structure to explore how changes to its sequence
or phosphorylation state affect biological activity. Such modifications can inform the design of
analogues with improved binding affinity or selectivity for specific kinases or phosphatases, thereby
honing therapeutic precision.
Lastly, the peptide is also used in biomarker discovery. As it
participates in signaling pathways often dysregulated in disease, its phosphorylation patterns can serve
as potential biomarkers for the diagnosis or prognosis of certain conditions. Researchers are able to
use this peptide to identify and validate these markers, providing tools for patient stratification and
personalized medicine approaches.
In summary, Ac-Tyr(PO3H2)-Tyr(PO3H2)-Tyr(PO3H2)-Ile-Glu-OH is
integral to various stages of drug discovery and development processes. Its ability to mimic natural
phosphorylation events allows researchers to dissect the complex biochemical interactions at play in
disease and to develop targeted strategies for therapeutic intervention.
What challenges might
researchers face when working with Ac-Tyr(PO3H2)-Tyr(PO3H2)-Tyr(PO3H2)-Ile-Glu-OH, and how can they
overcome them?
While Ac-Tyr(PO3H2)-Tyr(PO3H2)-Tyr(PO3H2)-Ile-Glu-OH is a powerful tool in
biological research, numerous challenges may arise when working with it. These challenges predominantly
originate from its chemical nature and the specific experimental conditions required to preserve its
functional integrity.
A significant issue derives from its phosphorylation state, as the presence
of phosphate groups can render the peptide more susceptible to degradation, particularly by phosphatases
present in biological samples. To overcome this, researchers must ensure that experimental protocols
include phosphatase inhibitors to preserve the phosphorylated state of the peptide throughout the
experiment. Additionally, storage conditions should be optimized to prevent degradation, often requiring
refrigeration and protection from light to maintain stability.
Another challenge is achieving the
desired solubility, which is affected by the highly charged nature of the peptide due to its phosphate
groups. Researchers may need to experiment with different solvents and buffer systems to find a suitable
one that maintains solubility without affecting the peptide's function. Often, slightly acidic or
neutral pH buffers are used to balance solubility and activity, also preventing undesired
aggregation.
Furthermore, the negatively charged phosphate groups can also lead to non-specific
binding interactions in complex biological assays. Researchers can address this issue by optimizing salt
concentrations and using specific detergents or blocking agents that minimize non-specific interactions
without impairing the peptide's interaction with its target enzymes or proteins.
Analytical
challenges are also apparent: detecting and quantifying such peptides in biological assays can be
difficult due to their post-translational modification state. Techniques such as mass spectrometry,
often coupled with advanced separation methods like high-performance liquid chromatography (HPLC), may
be employed to accurately detect and quantify the peptide amongst a mixture of biomolecules with high
precision.
Finally, when using this peptide in binding studies or activity assays, ensuring its
structural integrity is critical. Researchers should perform preliminary stability tests under
experimental conditions to determine the optimal timeframe for usage. This helps in ameliorating any
time-dependent degradation or conformational changes that might affect experimental outcomes.
By
carefully considering these factors and employing strategic experimental modifications, researchers can
effectively address the challenges associated with using Ac-Tyr(PO3H2)-Tyr(PO3H2)-Tyr(PO3H2)-Ile-Glu-OH,
thereby unleashing its full potential in advancing our understanding of phosphorylation-dependent
cellular mechanisms.
Why is Ac-Tyr(PO3H2)-Tyr(PO3H2)-Tyr(PO3H2)-Ile-Glu-OH considered an
exemplary model in the study of protein
interactions?
Ac-Tyr(PO3H2)-Tyr(PO3H2)-Tyr(PO3H2)-Ile-Glu-OH is considered an exemplary model in
studying protein interactions due to its ability to faithfully mimic the post-translational
modifications that occur in proteins, particularly phosphorylation. Phosphorylation is a critical
regulatory mechanism in cellular signaling, and this peptide, with its tri-phosphorylated tyrosines,
replicates the complex biological phenomena found in native phosphorylated proteins, providing a
simplified yet accurate model for scientific investigation.
One of the primary reasons this
peptide excels in modeling protein interactions is its structural similarity to naturally phosphorylated
motifs in signal transduction pathways. The peptide contains three phosphorylated tyrosine residues,
which are common in active sites and binding interfaces in cellular proteins. This makes it a perfect
analogue for studying interactions involving SH2 (Src Homology 2) domains, which specifically bind
phosphorylated tyrosine residues. Such interactions are pivotal in the relay of activation signals from
cell surface receptors to intracellular effectors and are central to various processes, including cell
growth and immune responses.
Furthermore, Ac-Tyr(PO3H2)-Tyr(PO3H2)-Tyr(PO3H2)-Ile-Glu-OH's
simplicity allows for a controlled experimental setup where researchers can observe the interactions in
a defined environment, free from the complexities of a full-length protein. It helps in elucidating
which factors contribute to binding specificity and affinity by varying experimental parameters such as
peptide concentration, presence of competing molecules, and environmental conditions.
In
addition, the peptide's highly charged nature, due to its phosphate groups, enables researchers to
explore how post-translational modifications influence the electrostatic landscape of protein-protein
interactions. Electrostatic complementarity often drives such interactions, and changes in
phosphorylation can lead to significant shifts in interaction patterns, thus altering signal pathways.
Investigating these changes at a molecular level offers insights into how modifications can tune
cellular responses, presenting potential intervention points for therapeutic exploration.
The
data generated from studies using Ac-Tyr(PO3H2)-Tyr(PO3H2)-Tyr(PO3H2)-Ile-Glu-OH can be extrapolated to
understand pathological states where dysregulation of these interactions occurs, such as cancer and
autoimmune diseases. Findings can guide the development of small molecules or biologics that modulate
these interactions, thereby paving the way for novel therapeutic approaches to correct aberrant
signaling networks in disease contexts.
In summary,
Ac-Tyr(PO3H2)-Tyr(PO3H2)-Tyr(PO3H2)-Ile-Glu-OH's ability to representatively mimic phosphorylated motifs
within signaling pathways makes it an exceptional tool for probing the nuances of protein-protein
interactions, offering a window into the molecular intricacies of cellular communication and regulation.